ATYPICAL HEMOLYTIC UREMIC SYNDROME
Clinical trials for ATYPICAL HEMOLYTIC UREMIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL HEMOLYTIC UREMIC SYNDROME trials appear
Sign up with your email to follow new studies for ATYPICAL HEMOLYTIC UREMIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aHUS: phase 3 trial tests crovalimab to control rare disease
Disease control OngoingThis study tests a new medicine, crovalimab, in 83 adults and teens with a rare disease called atypical hemolytic uremic syndrome (aHUS). The goal is to see if crovalimab can control the disease by preventing damage to small blood vessels and kidneys. Participants receive crovali…
Matched conditions: ATYPICAL HEMOLYTIC UREMIC SYNDROME
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 04:37 UTC
-
New hope for kids with rare kidney disease: crovalimab trial underway
Disease control OngoingThis study tests a drug called crovalimab in 41 children with atypical hemolytic uremic syndrome (aHUS), a rare condition that causes blood clots and kidney damage. The goal is to see if the drug can control the disease and improve kidney function. Participants receive crovalimab…
Matched conditions: ATYPICAL HEMOLYTIC UREMIC SYNDROME
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 15, 2026 11:57 UTC